マルチプレックスPCRアッセイの世界市場レポート 2025年

マルチプレックスPCRアッセイ市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR13.4％で28億3,000万米ドルに成長します。予測期間の成長は、アプリケーション領域の拡大、ポイントオブケア診断薬に対する需要の高まり、個別化医療の成長、研究開発費の増加、健康意識の高まりと予防ヘルスケア、精密医療への注目の高まり、迅速で信頼性の高い診断検査に対する需要の高まりなどに起因しています。予測期間における主な動向としては、次世代シーケンシング（NGS）の統合、コンパニオン診断、デジタルPCR技術、自動化およびハイスループットシステム、ポイントオブケアおよびポータブルデバイス、カスタマイズおよび多重化機能、人工知能および機械学習、データ管理の強化、クラウドソリューションなどが挙げられます。

診断検査に対する需要の高まりは、マルチプレックスPCRアッセイ市場の拡大を促進すると予測されています。診断検査には、患者の疾患や状態の有無を判定するための手順や検査が含まれます。がんや糖尿病などの慢性疾患の有病率の増加により、効果的な管理のために早期かつ正確な診断が必要とされています。さらに、予防ヘルスケアの重視により、潜在的な健康問題を早期に発見するための定期的な検査が推進されています。マルチプレックスPCRアッセイは、1つのサンプルから複数の病原体や遺伝子マーカーを同時に検出・分析することを可能にし、診断検査の効率と精度を高める。例えば、2024年7月、国民保健サービス（NHS）は、診断活動が2023年のパンデミック前のレベルを超え、2024年5月に実施された検査が前年比21％増加したと報告しました。さらに、2024年5月には240万件の診断検査が実施されました。このような診断検査需要の高まりは、マルチプレックスPCRアッセイ市場の成長を促進すると予想されます。

マルチプレックスPCRアッセイ市場の主要企業は、次世代定量PCR（qPCR）システムなどの自動化を統合し、高度な臨床診断や公衆衛生のための正確で柔軟な核酸定量を強化することに注力しています。次世代qPCRシステムは、ハイスループット、高精度、複数ターゲットの同時検出を実現し、診断精度と効率を向上させる。例えば、2023年11月、スイスを拠点とする診断システム・ソリューション・プロバイダーであるRoche Diagnostics Corporationは、LightCycler PROシステムを発表しました。この次世代qPCRプラットフォームは、高スループット、高精度、複数ターゲットの同時検出を実現し、温度均一性の向上、高度なソフトウェア、200種類以上のLightMix Modularおよび60種類以上のCE-IVDアッセイとの互換性を特徴としています。この発売は、マルチプレックスPCRアッセイ市場に自動化を導入し、臨床診断と公衆衛生を促進することを例証するものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界マルチプレックスPCRアッセイ PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のマルチプレックスPCRアッセイ市場：成長率分析
• 世界のマルチプレックスPCRアッセイ市場の実績：規模と成長, 2019-2024
• 世界のマルチプレックスPCRアッセイ市場の予測：規模と成長, 2024-2029, 2034F
• 世界マルチプレックスPCRアッセイ総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のマルチプレックスPCRアッセイ市場アッセイタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 平面アッセイ
• ビーズベースアッセイ
• 世界のマルチプレックスPCRアッセイ市場製品とサービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 消耗品
• 機器
• ソフトウェアとサービス
• 世界のマルチプレックスPCRアッセイ市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病気の診断
• 研究開発
• その他の用途
• 世界のマルチプレックスPCRアッセイ市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオ医薬品企業
• 臨床調査機関
• 学術調査機関
• 診断センター
• その他のエンドユーザー
• 世界のマルチプレックスPCRアッセイ市場平面アッセイのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• マイクロアレイベースのアッセイ
• DNAチップベースのアッセイ
• 世界のマルチプレックスPCRアッセイ市場ビーズベースアッセイの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ルミネックス Xmapアッセイ
• Magpixアッセイ
• フローサイトメトリーベースのビーズアッセイ

第7章 地域別・国別分析

• 世界のマルチプレックスPCRアッセイ市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のマルチプレックスPCRアッセイ市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• マルチプレックスPCRアッセイ市場：競合情勢
• マルチプレックスPCRアッセイ市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Siemens Healthineers
• Becton Dickinson and Company
• Agilent Technologies Inc.
• PerkinElmer Inc.
• Illumina Inc.
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• QIAGEN NV
• Tecan Group Ltd.
• DiaSorin SpA
• Bio-Techne Corporation
• Promega Corporation
• Randox Laboratories Ltd.
• BioFire Diagnostics Inc.
• Seegene Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• マルチプレックスPCRアッセイ市場2029：新たな機会を提供する国
• マルチプレックスPCRアッセイ市場2029：新たな機会を提供するセグメント
• マルチプレックスPCRアッセイ市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Multiplex PCR assays are advanced polymerase chain reaction techniques designed to simultaneously amplify and detect multiple DNA or RNA targets within a single reaction. This approach significantly enhances efficiency by enabling the analysis of various genetic markers or pathogens concurrently, offering comprehensive and cost-effective results.

The primary types of multiplex PCR assays include planar assays and bead-based assays. Planar assays are conducted on flat surfaces or platforms, such as microplates or slides, where arrays of probes are affixed to detect multiple targets in a single sample, facilitating efficient and high-throughput analysis. The product and service offerings encompass consumables, instruments, software, and services applicable to disease diagnosis, research and development, among other areas. End users of these technologies include biopharmaceutical companies, clinical research organizations, academic research institutes, and diagnostic centers.

The multiplex PCR assays market research report is one of a series of new reports from the business research company that provides multiplex PCR assays market statistics, including multiplex PCR assays industry global market size, regional shares, competitors with an multiplex PCR assays market share, detailed multiplex PCR assays market segments, market trends and opportunities, and any further data you may need to thrive in the multiplex PCR assays industry. This multiplex PCR assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The multiplex pcr assays market size has grown rapidly in recent years. It will grow from $1.51 billion in 2024 to $1.72 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to the increased prevalence of infectious diseases, increasing government funding and support, increasing adoption in clinical diagnostics, rise in genetic testing and personalized medicine, increasing use in academic and research institutions, advancements in bioinformatics and data analysis tools, rising healthcare expenditure.

The multiplex pcr assays market size is expected to see rapid growth in the next few years. It will grow to $2.83 billion in 2029 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to the expansion of application areas, rising demand for point-of-care diagnostics, growth in personalized medicine, an increase in research and development expenditures, rising health awareness and preventive healthcare, an increasing focus on precision medicine, and a and a rising demand for rapid and reliable diagnostic tests. Major trends in the forecast period include next-generation sequencing (NGS) integration, companion diagnostics, digital PCR technology, automation and high-throughput systems, point-of-care and portable devices, customization and multiplexing capabilities, artificial intelligence and machine learning, enhanced data management, and cloud solutions.

The growing demand for diagnostic testing is projected to drive the expansion of the multiplex PCR assay market. Diagnostic testing encompasses procedures or tests used to determine the presence or absence of diseases or conditions in patients. The increasing prevalence of chronic illnesses, such as cancer and diabetes, necessitates early and precise diagnosis for effective management. Furthermore, the emphasis on preventive healthcare promotes routine testing to identify potential health issues early. Multiplex PCR assays enable the simultaneous detection and analysis of multiple pathogens or genetic markers from a single sample, thereby enhancing the efficiency and thoroughness of diagnostic testing. For example, in July 2024, the National Health Service (NHS) reported that diagnostic activity surpassed pre-pandemic levels in 2023, with a 21% rise in tests conducted in May 2024 compared to the previous year. Additionally, 2.4 million diagnostic tests were performed in May 2024. This rising demand for diagnostic testing is expected to drive the growth of the multiplex PCR assay market.

Key players in the multiplex PCR assays market are focusing on integrating automation, such as next-generation quantitative PCR (qPCR) systems, to enhance precise and flexible nucleic acid quantification for advanced clinical diagnostics and public health. Next-generation qPCR systems provide high-throughput, accurate, and simultaneous detection of multiple targets, thus improving diagnostic accuracy and efficiency. For instance, in November 2023, Roche Diagnostics Corporation, a Swiss-based diagnostic system solutions provider, introduced the LightCycler PRO System. This next-generation qPCR platform offers high-throughput, precise, and simultaneous detection of multiple targets, featuring improved temperature uniformity, advanced software, and compatibility with over 200 LightMix Modular and 60 CE-IVD assays. This launch exemplifies the incorporation of automation in the multiplex PCR assays market, advancing clinical diagnostics and public health.

In July 2023, QIAGEN N.V., a Germany-based biotechnology company, partnered with Niba Labs. This partnership aims to advance research in genomic testing and personalized medicine by providing cutting-edge tools, data analysis, and expertise to foster innovation in biotechnology and healthcare. Niba Labs, a US-based biotechnology company, specializes in developing and manufacturing products for genomic research, molecular diagnostics, and personalized medicine.

Major companies operating in the multiplex pcr assays market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Illumina Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, Quanterix Corporation, NanoString Technologies, Standard BioTools Inc, Enzo Biochem Inc, SeraCare Life Sciences Inc, Agena Bioscience, Fluidigm Corporation

North America was the largest region in the multiplex PCR assays market in 2024. The regions covered in the multiplex pcr assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the multiplex pcr assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The multiplex PCR assays market consists of sales of reverse transcription multiplex PCR (RT-multiplex PCR), digital multiplex PCR, end-point multiplex PCR, multiplex ligation-dependent probe amplification (MLPA), and probe-based multiplex PCR. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Multiplex PCR Assays Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on multiplex pcr assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for multiplex pcr assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The multiplex pcr assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Assay Type: Planar Assay; Bead Based Assay
• 2) By Product And Services: Consumables; Instruments; Software And Services
• 3) By Application: Disease Diagnosis; Research And Development; Other Applications
• 4) By End User: Biopharmaceutical Companies; Clinical Research Organizations; Academic Research Institutes; Diagnostic Centers; Other End Users
• Subsegments:
• 1) By Planar Assay: Microarray-Based Assays; Dna Chip-Based Assays
• 2) By Bead Based Assay: Luminex Xmap Assays; Magpix Assays; Flow Cytometry-Based Bead Assays
• Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc; Abbott Laboratories; Danaher Corporation; Merck KGaA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Multiplex PCR Assays Market Characteristics

3. Multiplex PCR Assays Market Trends And Strategies

4. Multiplex PCR Assays Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Multiplex PCR Assays Growth Analysis And Strategic Analysis Framework

• 5.1. Global Multiplex PCR Assays PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Multiplex PCR Assays Market Growth Rate Analysis
• 5.4. Global Multiplex PCR Assays Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Multiplex PCR Assays Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Multiplex PCR Assays Total Addressable Market (TAM)

6. Multiplex PCR Assays Market Segmentation

• 6.1. Global Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Planar Assay
• Bead Based Assay
• 6.2. Global Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consumables
• Instruments
• Software And Services
• 6.3. Global Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disease Diagnosis
• Research And Development
• Other Applications
• 6.4. Global Multiplex PCR Assays Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biopharmaceutical Companies
• Clinical Research Organizations
• Academic Research Institutes
• Diagnostic Centers
• Other End Users
• 6.5. Global Multiplex PCR Assays Market, Sub-Segmentation Of Planar Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microarray-Based Assays
• Dna Chip-Based Assays
• 6.6. Global Multiplex PCR Assays Market, Sub-Segmentation Of Bead Based Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Luminex Xmap Assays
• Magpix Assays
• Flow Cytometry-Based Bead Assays

7. Multiplex PCR Assays Market Regional And Country Analysis

• 7.1. Global Multiplex PCR Assays Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Multiplex PCR Assays Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Multiplex PCR Assays Market

• 8.1. Asia-Pacific Multiplex PCR Assays Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Multiplex PCR Assays Market

• 9.1. China Multiplex PCR Assays Market Overview
• 9.2. China Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Multiplex PCR Assays Market

• 10.1. India Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Multiplex PCR Assays Market

• 11.1. Japan Multiplex PCR Assays Market Overview
• 11.2. Japan Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Multiplex PCR Assays Market

• 12.1. Australia Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Multiplex PCR Assays Market

• 13.1. Indonesia Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Multiplex PCR Assays Market

• 14.1. South Korea Multiplex PCR Assays Market Overview
• 14.2. South Korea Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Multiplex PCR Assays Market

• 15.1. Western Europe Multiplex PCR Assays Market Overview
• 15.2. Western Europe Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Multiplex PCR Assays Market

• 16.1. UK Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Multiplex PCR Assays Market

• 17.1. Germany Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Multiplex PCR Assays Market

• 18.1. France Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Multiplex PCR Assays Market

• 19.1. Italy Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Multiplex PCR Assays Market

• 20.1. Spain Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Multiplex PCR Assays Market

• 21.1. Eastern Europe Multiplex PCR Assays Market Overview
• 21.2. Eastern Europe Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Multiplex PCR Assays Market

• 22.1. Russia Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Multiplex PCR Assays Market

• 23.1. North America Multiplex PCR Assays Market Overview
• 23.2. North America Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Multiplex PCR Assays Market

• 24.1. USA Multiplex PCR Assays Market Overview
• 24.2. USA Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Multiplex PCR Assays Market

• 25.1. Canada Multiplex PCR Assays Market Overview
• 25.2. Canada Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Multiplex PCR Assays Market

• 26.1. South America Multiplex PCR Assays Market Overview
• 26.2. South America Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Multiplex PCR Assays Market

• 27.1. Brazil Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Multiplex PCR Assays Market

• 28.1. Middle East Multiplex PCR Assays Market Overview
• 28.2. Middle East Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Multiplex PCR Assays Market

• 29.1. Africa Multiplex PCR Assays Market Overview
• 29.2. Africa Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Multiplex PCR Assays Market Competitive Landscape And Company Profiles

• 30.1. Multiplex PCR Assays Market Competitive Landscape
• 30.2. Multiplex PCR Assays Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Multiplex PCR Assays Market Other Major And Innovative Companies

• 31.1. Siemens Healthineers
• 31.2. Becton Dickinson and Company
• 31.3. Agilent Technologies Inc.
• 31.4. PerkinElmer Inc.
• 31.5. Illumina Inc.
• 31.6. Sysmex Corporation
• 31.7. Bio-Rad Laboratories Inc.
• 31.8. QIAGEN NV
• 31.9. Tecan Group Ltd.
• 31.10. DiaSorin SpA
• 31.11. Bio-Techne Corporation
• 31.12. Promega Corporation
• 31.13. Randox Laboratories Ltd.
• 31.14. BioFire Diagnostics Inc.
• 31.15. Seegene Inc.

32. Global Multiplex PCR Assays Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Multiplex PCR Assays Market

34. Recent Developments In The Multiplex PCR Assays Market

35. Multiplex PCR Assays Market High Potential Countries, Segments and Strategies

• 35.1 Multiplex PCR Assays Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Multiplex PCR Assays Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Multiplex PCR Assays Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer